Terms: = Lung cancer AND RAP1GDS1, P52306, 5910, MGC118861, MGC118859, GDS1, ENSG00000138698 AND Treatment
3 results:
1. Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line treatment in Patients with Advanced Non-Small-Cell lung cancer and EGFR-Activating Mutations.
Mok TS; Cheng Y; Zhou X; Lee KH; Nakagawa K; Niho S; Chawla A; Rosell R; Corral J; Migliorino MR; Pluzanski A; Noonan K; Tang Y; Pastel M; Wilner KD; Wu YL
Drugs; 2021 Feb; 81(2):257-266. PubMed ID: 33331989
[TBL] [Abstract] [Full Text] [Related]
2. [Results of lung cancer Screening among Urban Residents in Kunming].
Lin Y; Ma J; Feng J; Zhang Q; Huang Y
Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):413-418. PubMed ID: 31315779
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].
Qiu LH; Wang HQ; Qian ZZ; Li W; Hou Y; Meng XR; Cui XZ; Hao XS
Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):743-6. PubMed ID: 20646489
[TBL] [Abstract] [Full Text] [Related]
